
Health consumers in 2026 are scrolling past AI-generated wellness content by the thousands. Creative that looks real, cites real evidence, and stays inside FTC and platform ad-claim rules is what actually converts.
Marketing creative and medical claims live in tension, and most agencies don't know where the line is
A headline that says 'clinically proven' or shows a before/after without substantiation is an FTC and platform ad-policy problem, not just a copywriting choice. Most creative shops write the version that converts best in testing, then find out later it got the ad account flagged or the claim retracted. Health and wellness brands need creative built by people who know which claims require substantiation before the asset ships, not after.
Wellness feeds are flooded with AI-generated faces and stock wellness imagery, and customers can tell
By 2026, AI-generated 'wellness influencer' content is common enough that health consumers actively discount it. Real patient likeness, real practitioner voice, and specific product detail now separate credible brands from the noise. Generic stock photography of smiling people in workout gear reads as filler, and health buyers who are already skeptical of the category treat it as a signal to move on.
Medical accuracy review is a bottleneck most marketing teams have no process for
Getting a claim checked by someone with clinical or regulatory judgment, on a timeline that doesn't kill the content calendar, requires a workflow most in-house marketing teams never build. Without it, brands pick one of two bad options: slow everything down for ad hoc legal review, or ship first and hope. Neither produces the volume of compliant creative a growth engine needs.
We start by mapping the actual claim risk in your category: which statements need substantiation, which imagery choices (before/afters, testimonials, clinical-looking visuals) draw platform or FTC scrutiny, and where your current creative is already exposed. That map becomes the guardrail for everything we produce, not a separate compliance pass bolted on at the end.
From there we build creative around real specificity – actual practitioners, actual patient or customer likeness where usage rights allow it, and product claims tied to what you can actually substantiate. This is slower than pulling stock photography, and it is also the only version that reads as credible to a health-conscious buyer who has already been burned by an overhyped supplement or app.
We set up a review workflow so medical accuracy checks happen in parallel with creative production, not after it. That means a clinical or regulatory reviewer signs off on claim language while the visual and copy are still in draft, so nothing sits waiting on a single bottleneck reviewer and nothing ships that has to be pulled back later.
Measurement covers both marketing performance and compliance status – which assets are converting, which claims have aged out of their supporting evidence, and where your <a href="/services/marketing/">marketing</a> calendar needs new substantiated angles. The brands that win trust in this category are the ones whose creative holds up to a skeptical read, and that only happens with medical accuracy built into the production line, not appended to it.
The wellness brands winning attention in 2026 aren't the ones with the most polished feed – they're the ones a skeptical customer can tell are real. Authenticity and claim accuracy have become the differentiator that generic creative can't fake.
The engagement runs as a 90-day build. Weeks 1-2: claim risk mapping – what your current creative gets wrong on compliance, and where the real trust gaps are with your specific customer. Weeks 3-6: production of the first wave of authentic, substantiated creative, built alongside a working medical review workflow rather than a one-time audit. Weeks 7-12: the review workflow gets handed off to run on a normal content cadence, with reporting on both conversion performance and compliance status.
This is different from a traditional creative agency engagement in one specific way: we treat medical accuracy as a production input, not a legal afterthought. A creative concept that can't be substantiated doesn't get built and then fixed later – it gets redirected before it costs you a production cycle.
First 30 days: audit of existing creative against current FTC and platform health-claim guidance, plus a look at what's actually driving trust for your specific vertical – supplements, medical devices, fitness apps, and clinical services all face different scrutiny. Weeks 30-60: production of the first authentic asset set, with medical review running in parallel rather than at the end. Weeks 60-90: the workflow moves to a repeatable cadence your team can run without us in every meeting.
On our side, you get a creative lead who has done this specific compliance-and-creative balancing act before, not a generalist account manager. You bring brand guidelines, whatever medical or clinical expertise you have in-house, and final say on claim risk tolerance. We bring the production process and the compliance mapping.
Reporting is monthly and covers two things together: standard creative performance (engagement, conversion by asset) and compliance status (which claims still have current supporting evidence, which assets are due for a refresh). Most engagements run 6-12 months, long enough to build out a full library of substantiated creative and hand off a workflow your team can keep running.
If your health & wellness company needs creative production leadership, we should talk.

Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Engagements typically run $15K-35K a month depending on content volume, how many product lines need distinct claim substantiation, and how much clinical review coordination is required. Companies with more regulatory exposure – supplements and medical devices, for instance – usually sit at the higher end because the review workload is heavier. Compare that to a full-time creative director plus a compliance consultant, which costs more and rarely has both skill sets in one person.
The first authentic asset set typically ships in the 30-60 day window, once claim mapping and review workflow are in place. Engagement and conversion signals on the new creative show up within the following month or two. Brand trust is slower – it compounds over months 4-6 as the audience sees consistent, substantiated content rather than a one-off campaign.
We build the review checkpoint into the production calendar, so your clinical or regulatory reviewer signs off on claim language while the asset is still in draft. That means we're scheduling around their availability from day one, not asking for a rushed final approval. If you don't have in-house medical review capacity, we can flag that gap early rather than let content ship without it.
Most agencies optimize for engagement and treat compliance as someone else's problem to catch before it ships. We build claim substantiation into the creative brief itself, so the asset that tests best is also the one that's actually defensible. That means fewer pulled assets and fewer surprises from a platform ad review.
We track conversion and engagement by asset the same way any creative team would, and layer in compliance status – which claims are current, which need refreshed evidence. The real signal over time is whether trust-driven metrics like repeat engagement and organic sharing improve, since that's what substantiated, authentic creative is built to move. We report this monthly, not just at the end of the engagement.
Supplement brands, medical device companies, fitness platforms, and clinical or wellness services that are producing enough content volume to need a real workflow, not a one-off campaign. It's the wrong fit for a company that just wants fast, unreviewed creative regardless of claim risk. The first step is the claim risk audit, which tells you exactly where your current creative is exposed before we build anything new.
Tuesday, October 27, 2026
Frank Growth – Episode 243 – Your Buyer Doesn’t Know They’re Looking with Sandra Moran
Tuesday, October 20, 2026
Frank Growth – Episode 242 – Why AI Slop Backfires with Nicole Cassese
Tuesday, June 16, 2026
Frank Growth – Episode 224 – The Bootstrapper’s Revenge with Alex Roy
Tuesday, October 6, 2026
Frank Growth – Episode 240 – Commerce for Weirdos with Bryan House
Ready to unlock your growth?
Book Free Call